Institutional investors purchased a net $15.8 million shares of CLVS during the quarter ended June 2019, and now own 48.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 2.7 Million shares of Clovis Oncology Inc